LumiraDx SARS-Cov-2 RNA STAR Full employs proprietary qSTAR technology, which types the basis of LumiraDx's issue of treatment molecular assays....
LumiraDx
LONDON, Jan. 21, 2021 /PRNewswire/ -- LumiraDx, the next-technology stage-of-care diagnostic testing business, declared right now multinational approvals of its...